Piper Sandler: 'DENTSPLY SIRONA (XRAY) most at risk; Own Manufacturers at Your Own Risk'

July 7, 2026 7:58 AM

Piper Sandler analyst Jason Bednar reiterated a Neutral rating and $13.00 price target on DENTSPLY SIRONA (NASDAQ: XRAY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found